▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2501 by analyst upside · 2026-10-16
BLLN
BillionToOne, Inc.
Healthcare · Market Cap $5B · P/E 158.0x
ANALYST PRICE TARGET
+25.6%
implied upside to consensus target
Current Price $102.73
Consensus Target $129.0
Bull Target $145.0
Bear Target $110.0
Analysts Covering 7
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
4
Hold
1
Sell
0
52-Week Low $61.96
52-Week High $150.44
YTD Return +15.1%
FUNDAMENTALS
Market Cap $5B
P/E Ratio (TTM) 158.0x
Forward P/E 69.2x
EPS (TTM) $0.65
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $397M
Profit Margin 8.3%
52-WEEK RANGE
52-Week Low $61.96
52-Week High $150.44
Current Price $102.73
Bear Target $110.0
Bull Target $145.0
● Now $102.73 ● Target $129.0
TRADING DATA
Avg Volume 678K
YTD Return +15.1%
Analyst Count 7
Consensus Buy
Upside to Target +25.6%
Last Updated 2026-10-16

ANALYST SUMMARY

BillionToOne, Inc. (BLLN) is currently trading at $102.73 with a Wall Street consensus price target of $129.0, implying potential upside of 25.6% over the next 12 months. 7 analysts currently cover BLLN, with a consensus rating of Buy - 86% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $145.0, while the most cautious has a target of $110.0.

BLLN operates in the Healthcare sector with a market capitalisation of $5B. The stock is up 15.1% year-to-date and is currently trading near the lower end of its 52-week range of $61.96 – $150.44.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for BLLN, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Guggenheim - Reiterated
Buy → Buy 2026-10-01 62% win rate (8 calls)
Canaccord Genuity ● Initiated
Buy 2026-09-02 Building track record
JP Morgan - Reiterated
Overweight → Overweight 2026-08-06 43% win rate (7 calls)
BTIG - Reiterated
Buy → Buy 2026-08-06 38% win rate (8 calls)
Guggenheim ● Initiated
Buy → Buy 2026-06-29 62% win rate (8 calls)
Guggenheim - Reiterated
Buy → Buy 2026-05-13 62% win rate (8 calls)
JP Morgan - Reiterated
Overweight → Overweight 2026-05-07 43% win rate (7 calls)
BTIG - Reiterated
Buy → Buy 2026-05-07 38% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
61
out of 100
Coverage depth
16/30
Consensus clarity
23/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →